Cronos Group Inc.

2.10+0.0800+3.96%Vol 1.75M1Y Perf -38.04%
Dec 1st, 2023 16:00 DELAYED
BID2.06 ASK2.10
Open2.03 Previous Close2.02
Pre-Market- After-Market2.08
 - -  -0.02 -0.91%
Target Price
3.76 
Analyst Rating
Moderate Buy 2.44
Potential %
79.05 
Finscreener Ranking
★★★★★     61.33
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+     59.82
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★     59.38
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
23.28 
Earnings Rating
Strong Sell
Market Cap800.34M 
Earnings Date
8th Nov 2023
Alpha-0.02 Standard Deviation0.20
Beta1.30 

Today's Price Range

2.012.10

52W Range

1.643.62

5 Year PE Ratio Range

-473.902.40

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
-1.46%
1 Month
16.09%
3 Months
2.54%
6 Months
16.09%
1 Year
-38.04%
3 Years
-75.72%
5 Years
-77.92%
10 Years
-

TickerPriceChg.Chg.%
CRON2.100.08003.96
AAPL191.241.29000.68
GOOG133.32-0.6000-0.45
MSFT374.51-4.4000-1.16
XOM102.990.25000.24
WFC45.020.43000.96
JNJ158.383.72002.41
FB196.640.99000.51
GE122.500.70000.57
JPM156.840.76000.49
Financial StrengthValueIndustryS&P 500US Markets
24.20
25.40
0.00
0.01
-35 008.60
Leverage Ratio 1.00
ProfitabilityValueIndustryS&P 500US Markets
30.40
-343.50
-325.60
836.30
-30.96
RevenueValueIndustryS&P 500US Markets
71.27M
0.19
65.35
127.89
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.03-0.0233.33
Q01 2023-0.04-0.0325.00
Q04 2022-0.05-0.14-180.00
Q03 2022-0.06-0.07-16.67
Q02 2022-0.06-0.060.00
Q01 2022-0.08-0.080.00
Q04 2021-0.10-0.36-260.00
Q03 2021--0.07-
Earnings Per EndEstimateRevision %Trend
12/2023 QR-0.02-100.00Negative
12/2023 FY-0.09-200.00Negative
3/2024 QR0.02120.00Positive
12/2024 FY0.02--
Next Report Date-
Estimated EPS Next Report-0.03
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume1.75M
Shares Outstanding381.11K
Shares Float352.15M
Trades Count5.13K
Dollar Volume3.59M
Avg. Volume1.79M
Avg. Weekly Volume1.19M
Avg. Monthly Volume1.76M
Avg. Quarterly Volume2.43M

Cronos Group Inc. (NASDAQ: CRON) stock closed at 2.02 per share at the end of the most recent trading day (a 3.06% change compared to the prior day closing price) with a volume of 2.32M shares and market capitalization of 800.34M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 665 people. Cronos Group Inc. CEO is Kurt Schmidt.

The one-year performance of Cronos Group Inc. stock is -38.04%, while year-to-date (YTD) performance is -20.47%. CRON stock has a five-year performance of -77.92%. Its 52-week range is between 1.64 and 3.616, which gives CRON stock a 52-week price range ratio of 23.28%

Cronos Group Inc. currently has a PE ratio of -4.50, a price-to-book (PB) ratio of 0.81, a price-to-sale (PS) ratio of 13.29, a price to cashflow ratio of -, a PEG ratio of -0.10, a ROA of -17.61%, a ROC of -17.43% and a ROE of -18.39%. The company’s profit margin is -30.96%, its EBITDA margin is -325.60%, and its revenue ttm is $71.27 Million , which makes it $0.19 revenue per share.

Of the last four earnings reports from Cronos Group Inc., there were 2 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.03 for the next earnings report. Cronos Group Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Cronos Group Inc. is Moderate Buy (2.44), with a target price of $3.76, which is +79.05% compared to the current price. The earnings rating for Cronos Group Inc. stock is Strong Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cronos Group Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cronos Group Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 16.70, ATR14 : 0.10, CCI20 : 29.35, Chaikin Money Flow : -0.05, MACD : 0.03, Money Flow Index : 62.26, ROC : -1.94, RSI : 54.85, STOCH (14,3) : 62.26, STOCH RSI : 0.69, UO : 45.29, Williams %R : -37.74), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cronos Group Inc. in the last 12-months were: Arye Weigensberg (Option Excercise at a value of $0), Jason Adler (Buy at a value of $2 378 034), Jeffrey Jacobson (Option Excercise at a value of $0), Michael Gorenstein (Option Excercise at a value of $0), Terrence Gregory Joseph Doucet (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (33.33 %)
3 (33.33 %)
3 (30.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
5 (55.56 %)
5 (55.56 %)
6 (60.00 %)
Moderate Sell
1 (11.11 %)
1 (11.11 %)
1 (10.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.44
Moderate Buy
2.44
Moderate Buy
2.50

Cronos Group Inc.

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany.

CEO: Kurt Schmidt

Telephone: +1 416 504-0004

Address: 720 King Street West, Toronto M5V 2T3, ON, CA

Number of employees: 665

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

54%46%

Bearish Bullish

55%45%

Bearish Bullish

56%44%

 

News

Stocktwits